BackKindred Biosciences Overview

Kindred Biosciences Current Cash

Track Kindred Biosciences's current cash ($47M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$46.72M
↑ 73.67% YoYΔ $19.82M vs prior year quarter

Peer trimmed avg / median

Loading

Kindred Biosciences Current Cash History

Loading

Kindred Biosciences vs. peers: Current Cash Comparison

Loading

Kindred Biosciences Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Kindred Biosciences (KIN) FAQ

Kindred Biosciences (KIN) currently reports a current cash of $47M as of June 2021. That compares with $27M in the prior-year period — up 73.7% year over year. Use the charts on this page to explore Kindred Biosciences's current cash history and peer comparisons.

Kindred Biosciences's current cash increased from $27M to $47M — a 73.7% year-over-year increase (period ending June 2021). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Kindred Biosciences reported $47M in current cash as of June 2021. That compares with $27M in the prior-year period — up 73.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $47M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Kindred Biosciences, and consider following KIN for alerts when major investors trade the stock.

Kindred Biosciences is classified in the Healthcare sector. On current cash, it currently shows $47M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing KIN with unrelated industries.